Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13
Closed -$608 1435
2025
Q1
$608 Buy
+13
New +$671 ﹤0.01% 1190
2023
Q3
Sell
-420
Closed -$12.7K 830
2023
Q2
$12.7K Sell
420
-25
-6% -$731 ﹤0.01% 688
2023
Q1
$13.7K Buy
+445
New +$16.9K ﹤0.01% 650
2021
Q3
Sell
-45
Closed -$2K 804
2021
Q2
$2K Hold
45
﹤0.01% 895
2021
Q1
$2K Buy
+45
New +$1.89K ﹤0.01% 716

Other funds holding SNV

CVA Family Office's SNV Position: Q2 2025 in Review

CVA Family Office sold out of Synovus (SNV) in Q2 2025, closing a stake of 13 shares — an estimated $608 sold.

CVA Family Office first reported a position in SNV in Q1 2021 and held it in 5 quarters. The position peaked at $13.7K in Q1 2023. 475 funds tracked by Wall St. Rank hold SNV as of Q2 2025.

  • CVA Family Office reported no remaining Synovus position as of Q2 2025 after selling out during the quarter.
  • CVA Family Office sold 13 Synovus shares in Q2 2025, an estimated $608.
  • CVA Family Office first reported a position in Synovus in Q1 2021 and held it in 5 quarters.
  • CVA Family Office's Synovus position peaked at $13.7K in Q1 2023.
  • 475 funds tracked by Wall St. Rank held Synovus as of Q2 2025.

Based on CVA Family Office's 13F filing for Q2 2025, filed 31 Jul 2025.